Dividend Focus Stock: Competitive Yield & Growth Potential Set This Healthcare Company Apart
Bucking its sector, this firm is maintaining both its innovation and its pricing power.
Our Dividend Informer analysts suggest taking a look at the long-term prospects of this top-quality, high-yielding pharmaceutical company, even if its valuation is stretched.
The full analysis on this featured dividend stock is available only to paid Dividend Informer subscribers.
Keep reading with a 7-day free trial
Subscribe to Dividend Informer to keep reading this post and get 7 days of free access to the full post archives.